+AptekaEPIGEN
Femara pack
Oncology

Femara — letrozole 2.5 mg, film-coated tablets, 30 tablets

Brand: Novartis

€186Price per pack
+ delivery from €40

Femara 2.5 mg — letrozole, 30 film-coated tablets, an oncology medicine from Novartis.

Order via MAX
Original medicine Photo and video report Tracked delivery
SPECIFICATIONS

Key information

Active ingredientletrozole
Strength2.5 mg
Dosage formfilm-coated tablets
Pack size30 tablets
Registration number669622
ManufacturerNovartis Farmacéutica, S.A. / Novartis Pharma S.A.S. / Salutas Pharma GmbH
Country of manufactureSpain
ABOUT THE MEDICINE

Full description

Femara — film-coated tablets containing the active ingredient letrozole at a strength of 2.5 mg. Pack size of this product: 30 tablets. Femara is used for hormone-dependent breast cancer in postmenopausal women in several officially approved treatment regimens. One tablet contains 2.5 mg of letrozole. For the standard Spanish presentation of Femara 2.5 mg, 30 tablets, the correct CN is 669622. Letrozole reduces oestrogen production by inhibiting aromatase. During long-term therapy, the doctor takes into account bone health, the lipid profile and concomitant risk factors.

FAQ

Frequently asked questions

What is Femara 2.5 mg used for?

For the treatment of certain forms of hormone-dependent breast cancer in postmenopausal women.

How does letrozole work?

It blocks aromatase and reduces the synthesis of oestrogens, which can stimulate the growth of a hormone-dependent tumour.

Why are the bones monitored during long-term treatment with Femara?

Lower oestrogen levels may reduce bone mineral density and increase the risk of osteoporosis.

Can Femara be used before menopause without a special regimen?

The standard indications are based on postmenopausal status; special regimens are determined by an oncologist.

How to order

Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.

This information is for reference only. Consult a doctor and read the official package leaflet before use.